Latest Distributions News

Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.

Ovanti Limited has addressed ASX concerns over its relationship with BNPLPay, clarifying key personnel roles, ownership structures, and cryptocurrency exposure tied to its Licence Agreement.

Desane Group Holdings has secured a seven-year lease extension with Signature Orthopaedics at its Lane Cove property, guaranteeing $5 million in rental income through 2032. This deal reinforces Desane’s strategy to maintain stable medium-term cash flows.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Streamplay Studio Limited reported a remarkable 827% increase in customer receipts for Q3 2025, driven by the full integration of Noodlecake Studios. With a robust cash balance of A$7.7 million and no debt, the company is well-positioned to accelerate growth across cloud gaming, game publishing, and emerging markets.

ReadCloud reports robust first half FY25 results, driven by a standout 29% revenue increase in its VET-in-Schools segment, alongside positive cash flow and strengthened operating leverage.

Delta Lithium has announced a substantial 46% increase in the gold resource at its Mt Ida Project, now exceeding 1.1 million ounces, alongside plans to spin off its gold assets into a new ASX-listed entity, Ballard Mining.

H&G High Conviction Limited has completed a major asset divestment, distributing over 63 million Hancock & Gore shares to its shareholders and signaling potential delisting and strategic shifts ahead.

Medical Developments International reported a robust Q3 FY25 with $8.9 million revenue and $1.7 million operating cashflow, driven by strong Penthrox demand and pricing. New distribution agreements in France and Switzerland position the company for further European expansion.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.